Should you buy RDOR3 right now? Stockgaide's algorithm rates RDOR3 as HOLD (technical signal), with a technical score of 45/100 at a last price of R$ 37.55. The 50-day average is below the 200-day average, and RSI sits at 52.1.
The technical setup for RDOR3 is currently neutral, with the stock trading at 37.63, above its 50-day SMA of 35.34 but below its 200-day SMA of 37.99. The RSI(14) at 52.12 indicates balanced momentum, while the MACD histogram sits near zero at 0.0101, suggesting a lack of strong directional thrust. The technical score of 45/100 reinforces a HOLD stance, with price closer to the 52-week low of 32.27 than the high of 48.41, but the stock has reclaimed the 50-day line.
Fundamentally, the P/E of 17.15 reflects a reasonable valuation for a major hospital operator, and the overall analyst view aligns with a HOLD, acknowledging the company's established market position without aggressive upside catalysts. The stock has remained within its range, showing no signs of excessive overvaluation or deep undervaluation, which supports the current waiting approach.
Investors should watch whether the price can decisively reclaim and hold above the 200-day SMA at 37.99, which would signal a shift in medium-term momentum. Conversely, a sustained break below the 50-day SMA at 35.34 could open the path toward the lower end of the range. Also monitor RSI for a move above 60 or below 40 to confirm direction, and any upcoming earnings or operational metrics from the hospital network. This is educational content, not investment advice.
Rule-based read from price and momentum indicators only — the score behind the technical signal above. Technical score: 45/100 (HOLD).
Stockgaide's AI currently rates RDOR3 as HOLD (technical signal), with a technical score of 45 out of 100 at a last price of R$ 37.55. This is educational content, not investment advice.
RDOR3's 50-day moving average (35.34) is below its 200-day moving average (37.99), which points to a medium-term downtrend.
RDOR3 has a 14-day RSI of 52.1, which places it in neutral territory (above 70 is overbought, below 30 is oversold).
RDOR3 last traded at R$ 37.55, against a 52-week range of R$ 32.27 to R$ 48.41 — about 33% of the way up that range.
Price targets, fundamentals deep-dive and an AI-written report — free, no signup.
Analyze RDOR3 now →